Tuberculosis of Exceptional Location in a Haemodialysis Patient
- 1 Unit of Nephrology, Dialysis and Renal Transplant, CHU Ibn Sina, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
- 2 Unit of Nephrology, Dialysis and Renal Transplant, CHU Ibn Sina, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
- 3 Unit of Nephrology, Dialysis and Renal Transplant, CHU Ibn Sina, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
- 4 Unit of Nephrology, Dialysis and Renal Transplant, CHU Ibn Sina, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
- 5 Unit of Nephrology, Dialysis and Renal Transplant, CHU Ibn Sina, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
- 6 Unit of Nephrology, Dialysis and Renal Transplant, CHU Ibn Sina, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
- 7 Unit of Nephrology, Dialysis and Renal Transplant, CHU Ibn Sina, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
Abstract
Background: Chronic haemodialysis patients present a lack of immunity responsible for a high incidence of tuberculosis of atypical and non-pulmonary localizations. Observation: We present a clinical case of a haemodialysis patient that presents an isolated localisation of prostate tuberculosis. He had no clinical signs but had laboratory findings of inflammatory syndrome and high Prostatic Antigen (PSA) level. The diagnosis was made by histopathologic study of the piece of prostatectomy. The patient received a six-month treatment with an initial two-month phase involving four anti-tuberculosis drugs (Rifampicin, Isoniazid, Ethambutol and Pyrazinamid) followed by a four-month maintenance phase involving two drugs (Isoniazid and Rifampicin). All drugs were adapted to his dialysis condition. We noticed no side effects of drugs. Conclusion: Clinical signs of prostatic tuberculosis are not specific, mainly made of an obstructive symptom. The diagnosis of prostatic tuberculosis is based on a bundle of clinical and biological arguments. Koch Bacilli (KB) can rarely be found in urine or sperm. In haemodialysis patient, it can be masked by non specific aspect of inflammatory syndrome. The management must be adjusted and a close following up of side effects is necessary.
- Bensouda, A. and Hachimi, M. (2007) La tuberculose génitale: A propos de 22 cas. African Journal of Urology, 13.
- Al-Efraij, K., Mota, L., Lunny, C., Schachter, M., Cook, V. and Johnston, J. (2015) The Union Risk of Active Tuberculosis in Chronic Kidney Disease: A Systematic Review and Meta-Analysis. International Journal of Tuberculosis and Lung Disease, 19, 1493-1499. https://doi.org/10.5588/ijtld.15.0081
- Manmadha Rao, T., Ram, R., Swarnalatha, G., Santhosh Pai, B.H., Ramesh, V., Shyam Sunder Rao, C., Diwaker Naidu, G. and Dakshinamurty, K.V. (2013) Tuberculosis in Haemodialysis Patients: A Single Centre Experience. Indian Journal of Nephrology, 23, 340-345.
- Abdelrahman, M., Sinha, A.K. and Karkar, A. (2006) Tuberculosis in End-Stage Renal Disease Patients on Hemodialysis. Hemodialysis International, No. 10, 360-364. https://doi.org/10.1111/j.1542-4758.2006.00130.x
- Benchekroun, A. (2003) La tuberculose prostatique: A propos de 2 cas. Annales d’urologie, 37, 120-122. https://doi.org/10.1016/S0003-4401(03)00032-9
- Rabesalama, S.S.E.N., Rakoto-Ratsimba, H.N., Rakototiana, A.F., Razafimahatratra, R., Raherison, R.A., Rantomalala, H.Y.H. and Randrianjafisamindrakotroka, N.S. (2010) Tuberculose Prostatique isolée. A propos d’un cas à Madagascar [Isolated Prostate Tuberculosis. Report of a Case in Madagascar]. Progrès en Urologie, 20, 314-316. https://doi.org/10.1016/j.purol.2009.06.004
- Sallami, S., Mejri, R., Chelif, M., Ben Salah, I., Ben Rhouma, S., Hafsia, G., Nouira, Y., Berais, N. and Horchani, A. (2009) La Tuberculose Prostatique Isolée. La Tunisie Médicale, 87, 407-408.
- Diel, et al. (2008) Predictive Value of a Whole Blood INF-γ Assay for the Development of Active Tuberculosis Disease after Recent Infection with Mycobacterium tuberculosis. American Journal of Respiratory and Critical Care Medicine, 177, 1164-1170.
- Fraisse, P., Barnig, C. and Bazin, D. (2012) Traitement de la tuberculose maladie dans les populations particulières. La Lettre du Pneumologue, 15, 26-31.
- La Lettre d’ICAR. Maniement des médicaments antituberculeux chez le patient insuffisant rénal.
- Harcouët, L. and Tod, M. (2007) Intérêt du suivi thérapeutique des antituberculeux chez l’adulte. La Lettre de l’Infectiologue, Tome, 22, 134-142.